Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines

Fulvestrant (ICI 182,780; ICI) is approved for the treatment of advanced metastatic breast cancer that is unresponsive to other endocrine therapies. Berries are frequently consumed for their antioxidant, anti-inflammatory, and anticancer potential. In this study, we tested the efficacy of two berry...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Woode, Denzel R., Aiyer, Harini S., Sie, Nicole, Zwart, Alan L., Li, Liya, Seeram, Navindra P., Clarke, Robert
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3549366/
https://ncbi.nlm.nih.gov/pubmed/23346406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/147828
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky